Authors:
Berger, AC
Gibril, F
Venzon, DJ
Doppman, JL
Norton, JA
Bartlett, DL
Libutti, SK
Jensen, RT
Alexander, HR
Citation: Ac. Berger et al., Prognostic value of initial pasting serum gastrin levels in patients with Zollinger-Ellison syndrome, J CL ONCOL, 19(12), 2001, pp. 3051-3057
Citation: J. Leyton et al., Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cells, CANCER LETT, 162(1), 2001, pp. 87-95
Authors:
Corleto, VD
Annibale, B
Gibril, F
Angeletti, S
Serrano, J
Venzon, DJ
Delle Fave, G
Jensen, RT
Citation: Vd. Corleto et al., Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome?, ALIM PHARM, 15(10), 2001, pp. 1555-1561
Authors:
Ito, T
Igarashi, H
Pradhan, TK
Hou, W
Mantey, SA
Taylor, JE
Murphy, WA
Coy, DH
Jensen, RT
Citation: T. Ito et al., GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity, PEPTIDES, 22(7), 2001, pp. 1139-1151
Authors:
Gibril, F
Lindeman, RJ
Abou-Saif, A
Sojamanesh, H
Roy, PK
Peghini, PL
Reynolds, JC
Lubensky, IA
Jensen, RT
Citation: F. Gibril et al., Retained gastric antrum syndrome - A forgotten, treatable cause of refractory peptic ulcer disease, DIG DIS SCI, 46(3), 2001, pp. 610-617
Authors:
Roy, PK
Venzon, DJ
Feigenbaum, KM
Koviack, PD
Bashir, S
Ojeaburu, JV
Gibril, F
Jensen, RT
Citation: Pk. Roy et al., Gastric secretion in Zollinger-Ellison syndrome - Correlation with clinical expression, tumor extent and role in diagnosis - A prospective NIH study of 235 patients and a review of 984 cases in the literature, MEDICINE, 80(3), 2001, pp. 189-222
Authors:
Cardelli, P
Fiori, A
Corleto, VD
Savi, MR
Granata, F
Ceci, F
Ferraguti, G
Potenza, RL
Delle Fave, G
Jensen, RT
Strom, R
Citation: P. Cardelli et al., Inhibitory effect of somatostatin on neutral amino acid transport in isolated brain microvessels, J NEUROCHEM, 78(2), 2001, pp. 349-357
Authors:
Bordi, C
Corleto, VD
Azzoni, C
Pizzi, S
Ferraro, G
Gibril, F
Delle Fave, G
Jensen, RT
Citation: C. Bordi et al., The antral mucosa as a new site for endocrine tumors in multiple endocrineneoplasia type 1 and Zollinger-Ellison syndromes, J CLIN END, 86(5), 2001, pp. 2236-2242
Authors:
Gibril, F
Venzon, DJ
Ojeaburu, JV
Bashir, S
Jensen, RT
Citation: F. Gibril et al., Prospective study of the natural history of gastrinoma in patients with MEN1: Definition of an aggressive and a nonaggressive form, J CLIN END, 86(11), 2001, pp. 5282-5293
Authors:
Tokita, K
Katsuno, T
Hocart, SJ
Coy, DH
Llinares, M
Martinez, J
Jensen, RT
Citation: K. Tokita et al., Molecular basis for selectivity of high affinity peptide antagonists for the gastrin-releasing peptide receptor, J BIOL CHEM, 276(39), 2001, pp. 36652-36663
Authors:
Mantey, SA
Coy, DH
Pradhan, TK
Igarashi, H
Rizo, IM
Shen, L
Hou, W
Hocart, SJ
Jensen, RT
Citation: Sa. Mantey et al., Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3, J BIOL CHEM, 276(12), 2001, pp. 9219-9229
Authors:
Tokita, K
Hocart, SJ
Katsuno, T
Mantey, SA
Coy, DH
Jensen, RT
Citation: K. Tokita et al., Tyrosine 220 in the 5th transmembrane domain of the neuromedin B receptor is critical for the high selectivity of the peptoid antagonist PD168368, J BIOL CHEM, 276(1), 2001, pp. 495-504
Authors:
Weber, HC
Walters, J
Leyton, J
Casibang, M
Purdom, S
Jensen, RT
Coy, DH
Ellis, C
Clark, G
Moody, TW
Citation: Hc. Weber et al., A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells, EUR J PHARM, 412(1), 2001, pp. 13-20
Authors:
Norton, JA
Alexander, HR
Fraker, DL
Venzon, DJ
Gibril, F
Jensen, RT
Citation: Ja. Norton et al., Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome, ANN SURG, 234(4), 2001, pp. 495-505
Authors:
Bordi, C
Azzoni, C
Ferraro, G
Corleto, VD
Gibril, F
Delle Fave, G
Lubensky, IA
Venzon, DJ
Jensen, RT
Citation: C. Bordi et al., Sampling strategies for analysis of enterochromaffin-like cell changes in Zollinger-Ellison syndrome, AM J CLIN P, 114(3), 2000, pp. 419-425
Citation: Rt. Jensen, Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment, CURR OPIN O, 12(4), 2000, pp. 368-377
Citation: Hc. Weber et al., Molecular organization of the mouse gastrin-releasing peptide receptor gene and its promoter, GENE, 244(1-2), 2000, pp. 137-149
Authors:
Ito, T
Hou, W
Katsuno, T
Igarashi, H
Pradhan, TK
Mantey, SA
Coy, DH
Jensen, RT
Citation: T. Ito et al., Rat and guinea pig pancreatic acini possess both VIP1 and VIP2 receptors, which mediate enzyme secretion, AM J P-GAST, 278(1), 2000, pp. G64-G74
Authors:
Gibril, F
Reynolds, JC
Lubensky, IA
Roy, PK
Peghini, PL
Doppman, JL
Jensen, RT
Citation: F. Gibril et al., Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: A prospective study, J NUCL MED, 41(10), 2000, pp. 1646-1656
Citation: C. Bordi et al., Fundic gland polyps: Do they arise as a by-product of hypergastrinemia in patients with Zollinger-Ellison syndrome? - Reply, HUMAN PATH, 31(7), 2000, pp. 890-890